Marpai, Inc. · OTC:MRAI
Marpai — Investor Presentation (October 2022)
20 slides from Marpai's investor presentation, Oct 14, 2022
Slide 1: Company Presentation October 2022
October 2022 | MarpaiHealth.com (NASDAQ: MRAI) Company Presentation Exhibit 99.1
Slide 2: Forward Looking Statements
| 2 Forward Looking Statements This presentation and the statements of representatives and partners of Marpai, Inc. (the “Company”) related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other U.S. Federal secu
Slide 3: Building the Health Plan of the Future
We use advanced AI, predictive analytics and SMART automation with the goal of reducing costs for employers while increasing health outcomes for their employees. Building the Health Plan of the Future HEALTH COSTS
Slide 4: Total addressable market for TPA fees from self-insured employers
Total addressable market for TPA fees from self-insured employers3 % of employers offering self-insured health plans which requires a TPA – Third Party Administrator2 Spending by self-insured health plans is one-third of total healthcare in America1 Employer Health Plans Cover 165 MILLION Americans
Slide 5: Exclusive AI-Powered Products Driving Member Health Up & Health Plan Costs Down
EXCLUSIVE AI-POWERED PRODUCTS Driving Member Health Up & Health Plans Costs Down Improve efficiency and eliminate errors, fraud, waste and abuse Prescription medication savings and transparency Ecosystem of VBC vendors and providers that guarantees quality AI-powered predictions and matching of memb
Slide 6: Targeted Member Matchmaking
Targeted Member Matchmaking Engaging the Members High Potential for Outcome AI Using Claims & Other Data
Slide 7: Data-driven, Multi-channel Member Activation
Data-driven, Multi-channel Member Activation Data Outreach Channels Measurement and Follow Ups to Non-Responsive Members Models (Rule Based & AI)
Slide 8: Marpai
M A R PA | We Gi) macro health” MARPAI
Slide 9: Acquisition of Maestro Health Doubles Size of Marpai
Acquisition of Maestro Health Doubles Size of Marpai Combined Company Summary Employee Lives 40,000+ Annual Revenues Approximately $40 million Cash on Balance Sheet $20+ million Healthcare Networks Aetna, CIGNA and more Value Added Services Marpai Rx, Clinical Care Management, Cost Containment Share
Slide 10: Maestro Health Key Facts
Signed deal on August 4, 2022 to acquire Maestro Health Corporate carve-out from AXA SA Large independent provider of TPA and benefits services founded in 2013 Primarily serves mid-market employer groups High degree of customer retention and satisfaction (70+ NPS) To date, generated substantial oper
Slide 11: More Solutions to Sell to Existing and Future Clients
Represents Maestro Health’s existing services Represents Marpai’s existing services More Solutions to Sell Existing and Future Clients \
Slide 12: Transaction Details
Purchase Price $22.1 million due on April 1, 2024 Payment Subject to Marpai meeting its obligations under the agreement, purchase price may be financed over 4 years by the seller with the last payment due on December 31, 2027 Cash Left on Balance Sheet $15.79 million Estimated Closing Date Estimated
Slide 13: Old World Payers vs. New World Tech-first Payers
Old World Payers: Established Tech Brings Revolutionizing Alternative BUCA’s Pay A Lot $$$ No Transparency No Control Full Insured Self Insured TPA’s Pay Less $$ More Risk Low Tech, Cumbersome New World Payers: Tech-First Lower Costs Automate & Simplify Processes Drive Healthier/Less Costly Behavior
Slide 14: Case Study: Savings of Self-insured vs. Fully Insured Plans
32% SAVINGS Per Employee Per Month (PEPM) by changing to Marpai’s self-insured plan1 Case Study: Savings Of Self-insured Vs. Fully Insured Plans American businesses are rapidly adopting self-insured plans for their flexibility and savings Washington D.C.- based Print Shop Note: 1 $769 PEPM was Unite
Slide 15: Investment Opportunity
Investment Opportunity High Margin Tech-driven cost reduction High Revenue Growth Superior product offering Highly Differentiated Predict, Prevent and Protect PROPRIETARY ALGORITHMS TECH PLATFORM INNOVATIVE BRAND LOYAL CUSTOMERS MOAT Goal: reduce cost to 1/3 of industry Higher AI-enabled quality car
Slide 16: Financials and Key Stats
Financials and Key Stats 6/30/2022 Cash Balance: $9.1 million1 Q2 2022 Revenue: $5.6 million Summary Financials Key Statistics Employee Lives: 21k3 Processed over 449k claims4 Filed Claims: $550 million Paid Claims: $183 million Claims Savings: $367 million Notes: 1 Marpai’s IPO with the exercise of
Slide 17: Capitalization
Marpai Health (NASDAQ: MRAI) Common Shares Outstanding 20,682,844 Warrants ($5.89 Weighted Average Exercise Price) 1,695,748 Options ($1.43 Weighted Average Exercise Price) 3,817,367 Fully Diluted Shares 26,159,959 Note: Figures as of September 1, 2022 Capitalization
Slide 18: Investment Summary
Predict Health States Prevent Costly Claims Organic + Acquisitions High Margin Claims Costs Highly Efficient Payer Investment Summary $22+ billion market opportunity addressed with highly differentiated AI products1 Source: 1 Company analysis based on estimated $44 PEPM x 39M employee lives (McLella
Slide 19: Seasoned Leadership Team and Board of Directors
Edmundo Gonzalez CEO Ronnie Brown COO Lutz Finger President, Product & Development Eli David Chief Science Advisor Art Hoath CRO Yoram Bibring CFO Yaron Eitan Chairman Damien Lamendola Director Gonen Antebi Director Mohsen Moazami Director Colleen DiClaudio Director Vincent Kane Director Yaron Eitan
Slide 20: What Will Be - Thank you